Skip to main content
Equibles

Long Focus Capital Management, LLC

Position in CLLS — Cellectis S.A.

CIK 1602716 SAN JUAN, PR
Back to CLLS Full portfolio

Position in CLLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,225,559
-$473,231 QoQ
Shares Held
2,741,853
-0.1% QoQ
Ownership
2.72%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2
of 27 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Long Focus Capital Management, LLC holds $196,301,316 across 7 Biotechnology names. CLLS ranks #7 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BNTX
BioNTech SE
 624,000 $58,063,200
2 INSM
INSMED Inc
 528,000 $56,295,360
3 AURA
Aura Biosciences, Inc.
 5,119,582 $36,349,032
4 MGTX
MeiraGTx Holdings plc
 1,080,300 $14,594,853
5 BCYC
Bicycle Therapeutics PLC
 3,310,687 $14,037,312
6 IOVA
Iovance Biotherapeutics, Inc.
 2,100,000 $8,736,000
7 CLLS
Cellectis S.A.
This page 		2,741,853 $8,225,559

All Filings in CLLS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,225,559 2,741,853
2026-03-31 $8,698,790 2,744,098
2025-12-31 $13,492,710 2,787,750
2025-09-30 $11,751,296 4,123,262
2025-06-30 $7,193,871 4,717,293
2025-03-31 $5,849,443 4,717,293
2024-12-31 $8,311,127 4,617,293
2024-09-30 $9,788,661 4,617,293
2024-06-30 $8,634,337 4,617,293
2024-03-31 $11,891,326 4,487,293
2023-12-31 $13,820,862 4,487,293
2023-09-30 $7,089,922 4,487,293
2023-06-30 $8,830,992 4,487,293
2023-03-31 $8,660,475 4,487,293
2022-12-31 $5,635,629 2,683,633
2022-09-30 $6,145,519 2,683,633
2022-06-30 $7,900,256 2,791,610
2022-03-31 $11,542,309 2,542,359
2021-12-31 $9,389,529 1,156,346